0 items USD 0.00Search
- Did you mean
- margin zoho lymphoma
Your search for "Marginal zone lymphoma" gave back 79978 results.
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The “Marginal Zone Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Marginal Zone Lymphoma Treatment sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Marginal Zone Lymphoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Bruton’s tyrosine kinase (BTK) is a key component of the B-cell receptor (BCR) signalling pathway. BTK is an important protein that is a regulator of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Highlights The global Non Receptor Tyrosine Protein Kinase TYK2 market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Non Receptor Tyrosine Protein Kinase TYK2 market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
